Immunotherapy of colorectal cancer
- 1 September 1992
- Vol. 70 (S3) , 1425-1433
- https://doi.org/10.1002/1097-0142(19920901)70:3+<1425::aid-cncr2820701534>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccineCancer Immunology, Immunotherapy, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cellsCancer Immunology, Immunotherapy, 1990
- Adjuvant chemoimmuno- and immunotherapy in Dukes' stage B2 and C colorectal carcinoma: A 7-year follow-up analysisJournal of Surgical Oncology, 1989
- Active immunotherapy in colorectal cancerSeminars in Surgical Oncology, 1989
- Controlled clinical trial of adjuvant immunotherapy with BCG and neuraminidase‐treated autologous tumour cells in large bowel cancerJournal of Surgical Oncology, 1989
- Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011JNCI Journal of the National Cancer Institute, 1988
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Adjuvant Therapy of Colon Cancer — Results of a Prospectively Randomized TrialNew England Journal of Medicine, 1984
- The General Immunopharmacology of LevamisoleDrugs, 1980